PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmultiple sclerosis
MeSH D009103 - multiple sclerosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020278:Cns demyelinating autoimmune diseases
0 Companies
0 Drugs
Success rate
D009103: 
Multiple sclerosis
D020528:Chronic progressive multiple sclerosis
0 Companies
0 Drugs
Success rate
D020529:Relapsing-remitting multiple sclerosis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBaclofen Baclofen  1988-07-21   
Methylprednisolone Methylprednisolone  2006-10-27   
Cyclophosphamide Neosar  1993-04-29   
Prednisolone Prednisolone  1999-05-28   
Prednisone Prednisone  1982-01-01   
Prednisolone Prelone  1986-02-04   
Dimethyl fumarate Dimethyl Teva  2022-12-12   
Novast LaboratoriesMethylprednisolone Methylprednisolone  2019-01-09   
Taro PharmaceuticalPrednisolone Flo-pred 2028-10-11 2008-01-17   
Dr Reddys LaboratoriesCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Prednisone Prednisone  2025-10-01   
MylanBaclofen Baclofen  2005-07-29   
Cladribine Cladribine  2011-10-06   
Prednisone Prednisone  1982-01-01   
Rising PharmaceuticalsMitoxantrone Mitoxantrone  2012-12-11   
Azathioprine Azathioprine  1999-12-13   
Dalfampridine Dalfampridine  2020-07-06   
Prednisolone Prednisolone  1982-01-01   
Prednisone Prednisone  1982-01-01   
Baclofen Baclofen  2021-03-05   
Johnson & JohnsonCladribine Leustatin  1993-02-26   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
76%
68/90
Phase 2
45%
60/133
Phase 3
58%
71/123
Approved: 31Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
...
11
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use